After former U.S. presidential candidate Hillary Clinton shone a spotlight on Mylan, its chief executive officer Heather Bresch was called before Congress, with Massachusetts Sen. Elizabeth Warren accusing the pharma boss of employing business tactics meant to keep costs unreasonably high.